Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001358403-16-000181
Filing Date
2016-05-09
Accepted
2016-05-09 16:13:42
Documents
48
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2016q110q.htm 10-Q 587943
2 EXHIBIT 10.1 exh101loanandsecurityagmt.htm EX-10.1 734511
3 EXHIBIT 31.1 a2016q1exh311.htm EX-31.1 13360
4 EXHIBIT 31.2 a2016q1exh312.htm EX-31.2 13523
5 EXHIBIT 32 a2016q1exh32.htm EX-32 11426
12 LOAN AND SECURITY AGREEMENT IMAGE herculesexhibitfor10q_image1.jpg GRAPHIC 206032
  Complete submission text file 0001358403-16-000181.txt   4140327

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT blcm-20160331.xml EX-101.INS 562146
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20160331.xsd EX-101.SCH 24260
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20160331_cal.xml EX-101.CAL 45080
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20160331_def.xml EX-101.DEF 94897
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20160331_lab.xml EX-101.LAB 370689
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20160331_pre.xml EX-101.PRE 196342
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

EIN.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 161631810
SIC: 2834 Pharmaceutical Preparations